Orabis 5 mg (Tablet)

Product Title

• Orabis 5 mg Tablet

Therapeutic Class

• Anti adrenergic agent (Beta blockers)
• Beta-adrenoceptor blocking drugs
• Beta-blockers

Indications

• Hypertension
• Angina
• Moderate to severe heart failure

Pharmacology

• Selective ß1 blocker
• Reduces heart rate and cardiac output
• Affects lipid metabolism
• High therapeutic reliability
• High absorption rate
• Renally eliminated metabolites
• CYPSA4 metabolism

Dosage & Administration

• Adult dosage: 5-20 mg once daily
• Titration interval: 2 weeks
• Initial dose for hepatic or renal impairment: 5 mg
• No established safety for children
• No usual dose adjustment in elderly

Interaction

• Contraindicated with other β-blocking agents
• Cautious with catecholamine-depleting drugs
• Potential exacerbation with clonidine withdrawal
• Careful use with myocardial depressants or A-V conduction inhibitors
• Combined use with negative inotropic calcium channel blockers

Contraindications

• Cardiogenic shock
• Overt heart failure
• Second or third degree A-V block
• Right ventricular failure secondary to pulmonary hypertension
• Sinus bradycardia

Side Effects

• Fatigue
• Dizziness
• Headache
• Gastrointestinal disturbances
• Cold or numb extremities
• Muscle weakness or cramps
• Breathing difficulties
• Bronchospasm in asthma or COPD patients

Pregnancy & Lactation

• Potential teratogenic and fetotoxic effects in animal studies
• Not recommended unless benefit justifies risk
• Small excretion in lactating rats

Precautions & Warnings

• Caution in adjusting dose for renal or hepatic impairment
• Increased reactivity in patients with severe anaphylactic reactions
• Potential unresponsiveness to usual doses of epinephrine in allergic patients

Storage Conditions

• Keep in a dry place away from light and heat
• Keep out of the reach of children

Chemical Structure

• Molecular Formula: C18H31NO4
• Chemical Structure Image URL: https://medex.com.bd/storage/res/g-res-135-bisoprolol-hemifumarate-chemical-structure-rpXCAgy2GIOFKWUs5Peu.svg

Commonly Asked Questions

• Orabis 5 mg Tablet is a beta-blocker medication
• Used for High blood pressure (hypertension), Chest pain (angina), and Heart failure
• Should be taken by mouth once daily, preferably at the same time each day
• Common side effects include Dizziness, Fatigue, Headache, Slow heart rate, Difficulty breathing, and Cold hands and feet
• Safe to take but consult a doctor for various health conditions
• Should be taken after food in a prescribed dosage
• Store in a cool dry place and in its original packaging, away from children and pets

Dimensions

• Tablet form

Color Options

• N/A

Material

• N/A

Technical Specifications

• Bisoprolol fumarate
• Single daily dose for therapeutic reliability
• Selective ß1 blocker
• High absorption rate and bioavailability

Design Elements

• Cardiovascular medication
• Selective action on ß1 adrenergic receptors

Usability Features

• Hypertension management
• Angina management
• Heart failure management

Manufacturer

• N/A

Brand Name

• Orabis

Model Number

• 5 mg Tablet

EAN-13

• N/A

UPC

• N/A

Warranty

• N/A

Power Source

• N/A

Special Features

• Selective ß1 blocking action

Additional Accessories

• N/A

Compatible Devices

• N/A

Sustainability Certifications

• N/A

Product Certifications

• N/A

Installation Method

• Oral administration

Selling Units

• Single tablet

Packaging Options

• Original packaging

Product Weight

• N/A

Recommended Age

• Adult use only

User Manual

• Consult healthcare professional for usage instructions

Assembly Required

• None

Batteries Required

• N/A

Batteries Included

• N/A

Related Brands

• Ancor 2.5 mg (Tablet) - aristopharma-ltd
• Ancor 5 mg (Tablet) - aristopharma-ltd
• Ancor 10 mg (Tablet) - aristopharma-ltd
• Betabis 2.5 mg (Tablet) - acme-laboratories-ltd
• Betabis 5 mg (Tablet) - acme-laboratories-ltd